Related references
Note: Only part of the references are listed.Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
Florence Baychelier et al.
BLOOD (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer
Ahmed El-Gazzar et al.
JOURNAL OF IMMUNOLOGY (2013)
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias
Hakan Norell et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
Franco Locatelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution
Peter Parham et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Melanoma Cells Inhibit NK Cell Functions-Letter
Giuseppe Sconocchia et al.
CANCER RESEARCH (2012)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New Approaches to Graft Engineering for Haploidentical Bone Marrow Transplantation
Rupert Handgretinger
SEMINARS IN ONCOLOGY (2012)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells
Paola Vacca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
Heather J. Symons et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Thomas Klingebiel et al.
BLOOD (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
Jennifer A. A. Gubbels et al.
MOLECULAR CANCER (2010)
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
Francesca Bellora et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Daniela Pende et al.
BLOOD (2009)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference
Franco Locatelli et al.
CLINICAL IMMUNOLOGY (2009)
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
Gabriella Pietra et al.
INTERNATIONAL IMMUNOLOGY (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
T. Sutlu et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Mirna Balsamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction
Guiseppe Sconocchia et al.
NEOPLASIA (2009)
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor
Martin Stern et al.
BLOOD (2008)
Human natural killer cells exposed to IL-2, IL-125 IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells
Sophie Agaugue et al.
BLOOD (2008)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias
Alessandro Moretta et al.
IMMUNOLOGICAL REVIEWS (2008)
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D
Mathias Krockenberger et al.
JOURNAL OF IMMUNOLOGY (2008)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari et al.
BLOOD (2008)
Searching for alternative hematopoietic stem cell donors for pediatric patients
V. Rocha et al.
BONE MARROW TRANSPLANTATION (2008)
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells
Elke Pogge von Strandmann et al.
IMMUNITY (2007)
Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells
Hiroshi Chinen et al.
GASTROENTEROLOGY (2007)
KIR2DS1-positive NK cells mediate alloresponse against the C2HLA-KIR ligand group in vitro
Joseph H. Chewning et al.
JOURNAL OF IMMUNOLOGY (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function
Pedro Roda-Navarro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
T Feuchtinger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors
B Le Maux Chansac et al.
JOURNAL OF IMMUNOLOGY (2005)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
D Pende et al.
BLOOD (2005)
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
AG Freud et al.
IMMUNITY (2005)
Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation
C Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
G Ferlazzo et al.
JOURNAL OF IMMUNOLOGY (2004)
Different checkpoints in human NK-cell activation
L Moretta et al.
TRENDS IN IMMUNOLOGY (2004)
The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity
C Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation
HG Shilling et al.
BLOOD (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Natural killer cells and dendritic cells: Rendezvous in abused tissues
A Moretta
NATURE REVIEWS IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
FR Villegas et al.
LUNG CANCER (2002)
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
D Cosman et al.
IMMUNITY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
